Predictive value of tumor growth rate during previous treatment for tumor response to regorafenib (REGO) and trifluridine/tipiracil (TFTD) in metastatic colorectal cancer (mCRC).

Kawakami, T; Masuishi, T; Kawamoto, Y; Omae, K; Muranaka, T; Nakatsumi, H; Yuki, S; Komatsu, Y; Yamazaki, K; Onozawa, Y; Yasui, H; Tajika, M; Kadowaki, S; Taniguchi, H; Muro, K

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):